MHC class II deficiency: a disease of gene regulation.
Villard
J
J
Immunology and Transplant Unit, Division of Immunology and Allergology, Geneva University Hospital, Geneva, Switzerland. Jean.Villard@hcuge.ch
Masternak
K
K
Lisowska-Grospierre
B
B
Fischer
A
A
Reith
W
W
D004268:DNA-Binding Proteins / Q000235:genetics; D005786:Gene Expression Regulation / Q000235:genetics*; D005802:Genes, MHC Class II / Q000235:genetics* / Q000276:immunology; D018740:Genetic Heterogeneity; D006801:Humans; D009687:Nuclear Proteins; D000071701:Regulatory Factor X Transcription Factors; D016511:Severe Combined Immunodeficiency / Q000150:complications / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D015534:Trans-Activators / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D004268:DNA-Binding Proteins; C083728:MHC class II transactivator protein; D009687:Nuclear Proteins; C093524:RFX5 protein, human; C117892:RFXANK protein, human; D000071701:Regulatory Factor X Transcription Factors; D015534:Trans-Activators; D014157:Transcription Factors